Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA Therapeutics™ to create a new generation of transformative medicines for patients, announced today the appointment of Israel Ruiz, Executive Vice President and Treasurer of the Massachusetts Institute of Technology, to the company's Board of Directors, where he will serve as Audit Committee Chair...